Opioids - STAT

Pharmalot By Ed Silverman

Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs

Pharmalot By Ed Silverman

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

Pharmalot By Ed Silverman

Purdue law firm hires Justice Department lawyer who investigated the opioid maker

Pharmalot By Ed Silverman

Lawmakers release trove of Purdue documents detailing Sackler family’s involvement in opioid sales

First Opinion By Richard Bottner, Christopher Moriates, and Matthew Stefanko

Stigma is killing people with substance use disorders. Health care providers need to rid themselves of it

Pharmalot By Ed Silverman

For two decades, the FDA approval process for opioids had numerous shortcomings, study finds

Pharma By Ed Silverman

Pharmalittle: Biden getting more pharma donations than Trump; FDA safety plan not ‘well suited’ for opioids

Opioid photo illustration opioid overdose

Pharma By Ed Silverman

An FDA safety program is failing to stem the opioid crisis — and manufacturers are mostly to blame

Pharmalot By Ed Silverman

Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus

Pharmalot By Ed Silverman

Court rules New York can collect taxes from drug makers and wholesalers to address opioid crisis

Pharmalot By Ed Silverman

Pharmalittle: Sanofi drug fails to tackle serious Covid-19 cases; EC agrees to fund WHO Covax program

Pharmalot By Ed Silverman

Coalition urges Justice Department to seek criminal charges against opioid executives

First Opinion By Ashwini Sehgal

Lifetime risk: a new way to understand deaths from firearms and drug overdoses

Pharmalot By Ed Silverman

Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits

Pharmalot By Ed Silverman

Opioid prescriptions written for Medicare Part D beneficiaries continues to drop

Pharmalot By Ed Silverman

Pharmalittle: J&J to supply U.S. with 100 million Covid-19 vaccine doses; Feds seek $18 billion from Purdue in opioid probe

Pharmalot By Ed Silverman

Pharmalittle: Pharma execs nix meeting with Trump; Kodak wins big U.S. loan to fix medical supply chain

Pharmalot By Ed Silverman

Pharmalittle: Moderna gets $472 million as late-stage Covid-19 vaccine trial begins; EU turns away from WHO vaccine effort

Health By Lev Facher

FDA says opioid labels must include information about naloxone

Politics By Amy Sokolow

Opioid overdoses have skyrocketed amid the coronavirus, but states are nevertheless slashing addiction treatment program budgets

Pharmalot By Ed Silverman

Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir

Pharmalot By Ed Silverman

Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals

Pharmalot By Ed Silverman

Pharmalittle: Glaxo aims for 1 billion doses of a Covid-19 vaccine booster; Pence aide holds lots of pharma stocks

Pharmalot By Ed Silverman

Pharmalittle: Merck enters Covid-19 vaccine race; pharma alarmed by push for U.S.-only supply chain

First Opinion By David A. Patterson Silver Wolf

Most Read

Purdue will plead guilty to federal charges, reaches $8.3 billion deal over opioid crisis

Why fentanyl is deadlier than heroin, in a single photo

As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies

The history of OxyContin, told through unsealed Purdue documents

I thought I understood the Sacklers’ opioid empire. Startling documents I found showed I was wrong

Lawmakers ask Justice Department to consider criminal charges against Purdue execs and the Sacklers

State treasurers urge Cardinal Health shareholders to reject CEO bonus over opioid crisis

Purdue Pharma, maker of OxyContin, settles opioids lawsuit in Oklahoma

All Coverage

Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

Purdue law firm hires Justice Department lawyer who investigated the opioid maker

Lawmakers release trove of Purdue documents detailing Sackler family’s involvement in opioid sales

Stigma is killing people with substance use disorders. Health care providers need to rid themselves of it

For two decades, the FDA approval process for opioids had numerous shortcomings, study finds

Pharmalittle: Biden getting more pharma donations than Trump; FDA safety plan not ‘well suited’ for opioids

An FDA safety program is failing to stem the opioid crisis — and manufacturers are mostly to blame

Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus

Court rules New York can collect taxes from drug makers and wholesalers to address opioid crisis

Pharmalittle: Sanofi drug fails to tackle serious Covid-19 cases; EC agrees to fund WHO Covax program

Coalition urges Justice Department to seek criminal charges against opioid executives

Lifetime risk: a new way to understand deaths from firearms and drug overdoses

Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits

Opioid prescriptions written for Medicare Part D beneficiaries continues to drop

Pharmalittle: J&J to supply U.S. with 100 million Covid-19 vaccine doses; Feds seek $18 billion from Purdue in opioid probe

Pharmalittle: Pharma execs nix meeting with Trump; Kodak wins big U.S. loan to fix medical supply chain

Pharmalittle: Moderna gets $472 million as late-stage Covid-19 vaccine trial begins; EU turns away from WHO vaccine effort

FDA says opioid labels must include information about naloxone

Opioid overdoses have skyrocketed amid the coronavirus, but states are nevertheless slashing addiction treatment program budgets

Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir

Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals

Pharmalittle: Glaxo aims for 1 billion doses of a Covid-19 vaccine booster; Pence aide holds lots of pharma stocks

Pharmalittle: Merck enters Covid-19 vaccine race; pharma alarmed by push for U.S.-only supply chain

Real-time data are essential for Covid-19. They’re just as important for the opioid overdose crisis